Skip to main content
OpenTrials
Completed

NCT Number: NCT02735772

Transobturator Approach for Paravaginal Repair

A new technique for Applying sutures to the white line in paravaginal repair.

Completed

Looking for future studies?

Notify Me

Key information

About this study

A new trial for transobturator repair of the paravaginal defect.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • paravaginal defect cystocele
  • midline and paravaginal defect cystocele

Exclusion criteria

  • uterine descent
  • previous cystocele surgery

Treatment and study plan

transobturator approach for paravaginal repair

Procedure

using TOT needle to apply suturs to white line

Primary outcomes

  1. success rate

    Time frame: 6 months

    Evaluation of the postoperative degree of anterior vaginal wall descent using pelvic organ prolapse quantitative system

Secondary outcomes

  1. lateral vaginal fornices elevation

    Time frame: 3 month

    test is negative means success

  2. Operative time

    Time frame: 1 day

    Operative time

  3. Intraoperative blood loss

    Time frame: 1 day

    Blood loss during the operative procedure

  4. Complications rate

    Time frame: 1 week

    Intraoperative and postoperative complications

Sponsors and collaborators

Lead sponsor

Ain Shams Maternity Hospital

Other

Registry information

Official study title

Transobturator Approach for Paravaginal Repair a New Approach

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Apr 13, 2016
Registry last updated
Oct 8, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.